Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review: Comparative Effecti by Agency for Healthcare Resea And Quality, U. S. Department of Heal Human Services

Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review: Comparative Effecti

Agency for Healthcare Resea And Quality, U. S. Department of Heal Human Services

494 pages missing pub info (editions)

nonfiction health informative medium-paced
Powered by AI (Beta)
Loading...

Description

Allergic rhinitis is a widespread clinical problem, estimated to affect 20 to 40 percent of the population in the U.S. Inhalant allergens, such as plant pollens, characteristically cause seasonal rhinoconjunctivitis and/or asthma; whereas, cat dan...

Read more

Community Reviews

Loading...

Content Warnings

Loading...